Past events by AAPS-BADG  

May16th, 2024

(jointly with the AAPS Inhalation and Nasal Community)

Current Opportunities in Nasal Drug Delivery
Speaker: Julie D. Suman, R.Ph., Ph.D. (Vice President Scientific Affairs, Aptar Pharma)
Dry Powder Inhaler Manufacturing: Case Studies on How Powder Properties Influence Processing and Performance
Speaker: Irene Rossi, Ph.D. (Consultant Inhalation Technology , Harro Höfliger (DE))

November 8th, 2023

The Explanation For Why and Regulatory Implications When Bioavailability Calculations Exceed Unity

Speaker: Leslie Z. Benet, PhD
​​​​​​​Department of Bioengineering and Therapeutic Sciences
Schools of Pharmacy and Medicine, University of California San Francisco

May 11th, 2023

Predictive high-throughput screening of oligonucleotide lipid nanoparticle for gene silencing

Speaker: Chun-Wan Yen, PhD (Sr. Principal Scientist, Genentech)

October 3th, 2022

Beta-glucuronidase: roles in enterohepatic recirculation and prostate

Speaker: Abby C. Collier, PhD (Professor, The University of British Columbia)

June 6, 2022

Basic tenets of ADC PK/PD and examples of how M&S can be used to support MIDD of ADCs
Speaker:  Dhaval Shah, PhD (University of Buffalo )
Formulation Strategies for Antibody Drug Conjugates (ADCs)
Speaker: Rajiv Nayar, PhD  (HTD Biosystems)

February 23, 2022

Local Treatment of Non-Small-Cell Lung Cancer by Dry Powder Inhaler: A Spray Dried Bevacizumab Formulation
Speaker:  Kimberly B. Shepard, PhD (Lonza Bend, OR, USA )

December 6, 2021

Gamma-Hydroxybutyric Acid Toxicokinetics and Toxicodynamics: Role of Monocarboxylate Transporters
Speaker:  Marilyn E. Morris, PhD  (University at Buffalo )

July 29-30, 2021

Development of Inhalation Therapeutics (a joint symposium with PBSS)
Guenther Hochhaus (University of Florida)
Qi (Tony) Zhou (Purdue University)
Winlei Jiang (CDER, FDA)
Reinhard Vehring (University of Alberta)
Yoen-Ju Son (Genentech)
Ram Mahato (University of Nebraska)
Hugh Smyth (University of Texas, Austin)
Jennifer Wylie (Merck)

March 29, 2021

Developing Therapeutic Materials to Redirect Cellular Chatter
Speaker:  Juliane Nguyen, PharmD, PhD (University of North Carolina at Chapel Hill)

December 8, 2020

Challenges and Opportunities in Pharmaceutical Industry
Speaker:  Annette Bak, PhD (AstraZeneca)

February 11, 2020

Applying machine learning and artificial intelligence to the development of a pharmaceutical tablet (jointly with Bio2Device)
Speaker: Edward Yost (Genentech)

November 21st, 2019

Choosing Wisely: The Last Crusade for Oral Peptides
Speaker: Dennis H. Leung, PhD (Genentech)

The Best Model of a Cat Is a Cat
Synthetic biology and data sciences to navigate biological complexity
Speaker: Sridhar Govindarajan, PhD (Co-Founder/CIO – ATUM)

September 27th, 2018 

Workshop: Small Molecule Formulation Development — Strategies for challenging APIs (jointly with PBSS)

June 7th, 2018

Particle Engineering and Characterization of Pharmaceutical Solids for Small and Large Molecules
Speaker: Qi (Tony) Zhou, PhD – Purdue University

Cyclodextrins as Solubilization Tools for BCS Class II/IV Drugs & Biomolecules Stabilizers
Speaker: Carmen Popescu, PhD – Roquette America Inc.

March 8th, 2018 

Pharmaceutical Innovation in Academia
Speaker: Howard Maibach, MD, UCSF

Real-time GMP Manufacture of Injectable Formulations for Clinical Development: Where the Requirements of Science and Quality Meet
Speaker: Kevin M Kane, PhD, Quotient Sciences

October, 25th 2017 

Systemic Concentrations Can Limit the Oral Absorption of Poorly Soluble Drugs: An Investigation of Non-Sink Permeation Using Physiologically Based Pharmacokinetic Modeling
Speaker: Tom Chiang, Ph.D.,  Genentech, Inc

Defining in-vitro-in-vivo Relationships for Orally Inhaled and Nasal Drug Products
Speaker: Jag Shur, Ph.D., Nanopharm Ltd. UK
Photo of two men shaking handsPhoto of two men shaking hands

June 8, 2017

Back to the Future: Aerosol Treatment and Prevention of Tuberculosis 
Speaker: Anthony J Hickey, Ph.D.,RTI International, RTP, NC                   

3-D Printed Pharmaceutical Dosage
Speaker: Xiaoling Li, Ph.D., University of the Pacific, Stockton, CA  

March 30, 2017

Characterization of Polymorphs, Amorphous Solid Dispersions, and Proteins in Lyophilized Formulations Using Solid-State NMR Spectroscopy​​​​​​​
Speaker: Dr. Eric Munson, Professor in Pharmaceutical Sciences,
Univ. of Kentucky.

March 9, 2017

Systems based Pharmaceutics: Leveraging Mechanistic Process Modeling Tools to Meet Regulatory Requirements
Speaker: Dan Briado Senior Technical Consultant, Process Systems Enterprise Ltd. 

Developing Palatable Drug Products: It’s More than Yuck and Yum
Speaker: David A. Tisi, Technical Director, Senopsys LLC

June 19, 2014

Understanding Complex Systems: The Map is Not the Territory
Speaker: Dr. Rasmus Gronfeldt Winther, Associate Professor of Philosophy, UC Santa Cruz.

PKPD Considerations for the Preclinical Development of Antibody-Drug Conjugates
Speaker: Dr. Shraddha Sadekar, Senior Scientist, DMPK and Disposition, Merck Research Laboratories, Palo Alto.

Older Events


Pediatric Drugs – A Review of Commercially Available Oral Drug Products
Speaker: Dr. Robert Strickley, Principal Scientist, Gilead Sciences Inc.

Strengthening Weaker Joints: Discovery of a New Drug Candidate for Trasnthyrethin-Folding Diseases
Speaker: Dr. Mamoun Alhamadsheh, Dept. of Pharmaceutics & Medicinal Chemistry, University of the Pacific.


Overcoming the Cold-Chain: Designing a Novel Freeze-Stable Vaccine
Speaker: Aryo Sorayya, President, Engimata Inc.

Models and Their Utility in the Drug Development Process
Speaker: Dr.  Toufigh Gordi, President of PK/PD and Clinical Pharmacology Services, Rose & Co LLC.


Protein Particulates and Immunogenicity
Speaker: Dr. Valerie Quarmby,  Principal Scientist and Director, Genentech:

Immunogenicity in Biotherapeutic Development
Speaker: Dr. Hanns-Christian Mahler, Head Pharmaceutical Development & Supplies, F. Hoffmann-LaRoche Ltd., Pharmaceutical Division, Pharma Technical Development Biologics Europe: “To See or Not to See? – Particulates in Protein Pharmaceuticals”


Formulation Development of  Monoclonal Antibodies
Speaker: Dr. Steve Shire,  Staff Scientist, Late Stage Pharmaceutical Development, Genentech: “Challenges in the Development of Formulations for the Delivery of Monoclonal Antibody Therapeutics.”

Speaker: Dr. Mitra Mosharraf, Chief Scientific Officer, HTD Biosystems: “Strategies to Improve Dissolution Rate of Lyophilized High Dose Protein Formulations in Dual Chamber Syringes.”


“Oxidative Degradation of Pharmaceuticals”
Speaker: Dr. Christian Schoneich,  Takeru Higuchi Distinguished Professor and Chair, Dept. Pharmaceutical Chemistry, Univ. of Kansas: “Oxidative degradation of pharmaceuticals: mechanisms and commonalities between small molecules, peptides, and proteins.”
Speaker: Dr. Andrea Ji, Senior Scientist, Late Stage Pharmaceutical Development, Genentech: “Oxidative degradation of pharmaceutical excipients.”


“Solving Drug Metabolism Challenges”
Speaker: Cyrus Khojasteh, PhD, Group Leader, DMPK Genentech
Speaker: Jason Halladay, PhD, Scientist, DMPK Genentech


“New Approaches of Drug Delivery: from Particulates to Cells”
Speaker: Xin Guo, PhD: “Design of biocompatible pH-sensitive liposomes for drug and gene delivery”
Speaker: Kevin Healy, PhD: “Bioinspired Approaches for Drug Delivery and Tissue Engineering”


“Excipients and Drug Delivery”
Speaker: Narsi Rangachari, Ph.D. “Drug Delivery – A Prespective”
Speaker: Robert Strickley, Ph.D.  “Formulations in Drug Discovery…”


“The Development of Biosimilar Drugs, Opportunities and Challenges”


Why aren’t there more parenterally administered nanocarrier drug products? 
Speaker: Francis C. Szoka, PhD

Recent Innovations of liposomal products in drug development
Speaker: Rajiv Nayar, PhD


Pharmaceutical Excipients – Adding Functionality to Product Development
(joint event with CACO)


Antibody Drug Conjugate/The Prospect of Therapeutic Antibodies
Speakers:      Shrikant Deshpande, PhD/Xiaodong Yang, MD PhD


Risk Management and Protein Formulation in Drug Development
Speakers:       Vijay Chiruvolu, PhD, Tim Kamerzell, PhD


Poorly Soluble Drugs-Pharmaceutical Development Strategies and
Approaches for Pre Clinical Applications (joint event with CACO)
Speakers:     Ram Nyshadham, Karthik Nagapudi, Sreekanth Nadkarni, Sesha Neravennan